Neural Cell News 12.09 March 7, 2018 | |
| |
TOP STORYScientists found that TRPV1+ nociceptors suppressed protective immunity against lethal Staphylococcus aureus pneumonia. Targeted TRPV1+-neuron ablation increased survival, cytokine induction, and lung bacterial clearance. [Nat Med] Abstract | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Investigators used the CRISPR-Cas9 system to perform genome-wide gene-knockout screens for suppressors and enhancers of C9ORF72 dipeptide-repeat toxicity in human cells. They validated hits by performing secondary CRISPR-Cas9 screens in primary mouse neurons. [Nat Genet] Abstract | Press Release B-1a Lymphocytes Promote Oligodendrogenesis during Brain Development Researchers identified the subtypes of lymphocytes that are present in neonatal mouse brains and investigated their functions. They found that B-1a cells, a subtype of B cells, were abundant in the neonatal mouse brain and infiltrated into the brain in a CXCL13–CXCR5-dependent manner. [Nat Neurosci] Abstract Fast Direct Neuronal Signaling via the IL-4 Receptor as Therapeutic Target in Neuroinflammation Investigators demonstrated that intrathecal IL-4 treatment during the chronic phase of several experimental autoimmune encephalomyelitis models reversed disease progression without affecting inflammation. Amelioration of disability was abrogated upon neuronal deletion of IL-4R. They discovered direct neuronal signaling via the IRS1-PI3K-PKC pathway underlying cytoskeletal remodeling and axonal repair. [Sci Transl Med] Abstract Scientists dissected the molecular mechanism by which the transcription factor Insm1 promotes the generation of basal progenitors (BPs). Insm1 protein was most highly expressed in newborn BPs in mouse and human developing neocortex. [Neuron] Abstract | Graphical Abstract Elongator and Codon Bias Regulate Protein Levels in Mammalian Peripheral Neurons Familial dysautonomia (FD) results from mutation in IKBKAP/ELP1, a gene encoding the scaffolding protein for the Elongator complex. This highly conserved complex is required for the translation of codon-biased genes in lower organisms. The authors investigated whether Elongator serves a similar function in mammalian peripheral neurons, the population devastated in FD. [Nat Commun] Full Article The authors showed that the Itch/β-arrestin2 complex binds suppressor of fused (SuFu) and induces its Lys63-linked polyubiquitylation without affecting its stability. [Nat Commun] Full Article Investigators used single-cell RNA-seq to characterize dopaminergic (DA) neuron populations in the mouse brain at embryonic and early postnatal time points. These data facilitated unbiased identification of DA neuron subpopulations through their unique transcriptional profiles, including a postnatal neuroblast population and substantia nigra DA neurons. [Am J Hum Genet] Abstract The authors compared reprogramming efficiency of five different retinal cell types at two different stages of development. Retinal differentiation from each induced pluripotent stem cell (iPSC) line was measured using a quantitative standardized scoring system called STEM-RET and compared to the epigenetic memory. Neurons with the lowest reprogramming efficiency produced iPSC lines with the best retinal differentiation and were more likely to retain epigenetic memory of their cellular origins. [Cell Rep] Full Article | Graphical Abstract Researchers examined matrix metalloproteinases for potential roles in ventricular-subventricular zone stem cell niche development. MMP12 was found to promote appropriate niche cellular arrangements, the formation of specialized niche extracellular matrix, and the translational planar cell polarity of ependymal cells that surround and support niche neural stem cells. [Stem Cell Reports] Full Article | Graphical Abstract Scientists used hiPSC-derived neurons to test a compound that stabilizes the retromer, a highly conserved multiprotein assembly that plays a pivotal role in trafficking molecules through the endosomal network. [Stem Cell Reports] Full Article | Graphical Abstract The termination of cell proliferation concomitant to neuronal maturation following methylphenidate treatment was observed in all of the cell-models tested: murine neural stem-, rat PC12- and the human SH-SY5Y-cells. [Transl Psychiatry] Full Article Investigators showed that the HDAC inhibitor, sodium butyrate, promotes mitochondrial biogenesis via the NRF-1/Tfam axis in embryonic hippocampal progenitor cells and neuroprogenitor-like PC12-NeuroD6 cells, thereby enhancing their neuronal differentiation competency. [Cell Death Dis] Full Article | |
| |
REVIEWSRedox Metals Homeostasis in Multiple Sclerosis and Amyotrophic Lateral Sclerosis: A Review Scientists describes the physiology of redox metals that produce oxidative stress, which in turn leads to cascades of immunomodulatory alteration of neurons in multiple sclerosis and amyotrophic lateral sclerosis. [Cell Death Dis] Full Article Visit our reviews page to see a complete list of reviews in the neural cell research field. | |
| |
SCIENCE NEWSIonis Pharmaceuticals Inc. announced the presentation of positive top-line data from a completed Phase I/II study of IONIS-HTTRx in people with early stage Huntington’s disease. [Press release from Ionis Pharmaceuticals, Inc. discussing research presented at the 13th Annual CHDI Huntington’s Disease Conference, Palm Springs] Press Release | |
Get an overview of 3D brain models and their applications. Learn More | |
| |
INDUSTRY NEWSAsterias Provides Update for Its AST-OPC1 Phase I/IIa Clinical Trial in Severe Spinal Cord Injury Asterias Biotherapeutics, Inc. provided additional data from the company’s ongoing Phase I/IIa SCiStar study designed to evaluate the safety and potential efficacy of AST-OPC1 in the treatment of severe cervical spinal cord injury. [Asterias Biotherapeutics Inc.] Press Release Tocagen Inc. announced the European Medicines Agency has granted orphan medicinal product designation to Toca 511 (vocimagene amiretrorepvec) & Toca FC (flucytosine) for the treatment of patients with glioma. [Tocagen Inc.] Press Release Constant Pharmaceuticals, LLC Announces Japanese Patent Issuance for TXA302 in Treatment of Stroke Constant Pharmaceuticals LLC announced that the Japanese Patent Office has issued a patent covering the use of TXA302 in the treatment of stroke. [Constant Pharmaceuticals LLC] Press Release Apexigen, Inc. and the Pediatric Brain Tumor Consortium, announced a clinical trial collaboration to evaluate Apexigen’s APX005M, an investigational immune activating compound that targets CD40, in pediatric patients with recurrent or refractory brain tumors. [Apexigen, Inc.] Press Release Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Epitinib in Glioblastoma in China Hutchison China MediTech Limited has initiated a Phase Ib/II proof-of-concept study of epitinib in glioblastoma patients with epidermal growth factor receptor gene amplification in China. [Hutchison China MediTech Limited] Press Release | |
| |
POLICY NEWSRise of Nationalist and Populist Parties Has Italian Scientists Worried The outcome of parliamentary elections in Italy was a stunning victory for populist and nationalist parties, and a clear warning to Italy’s political establishment and the European Union. But some in Italy worry that the results may also have a negative impact on science. [ScienceInsider] Editorial What Researchers Can Expect from China’s Top-Level Political Meetings As Chinese leaders gather for the government’s most significant meetings of the year, researchers are anticipating major policy announcements for science and innovation that could shape the country’s research agenda for years. [Nature News] Editorial New NSF Rules on Sexual Harassment Leave Many Questions Unanswered The National Science Foundation (NSF) in Alexandria, Virginia, hopes that its new policy on sexual harassment will spur universities to deal more aggressively with the pervasive problem. But the additional reporting requirements, which will be officially published in the Federal Register, are far from a definitive statement about how NSF plans to deal with this complex and sensitive subject. [ScienceInsider] Editorial
| |
EVENTSNEW MDI Biological Laboratory: Applications of Organoid Technology Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Research Associate – Cell Biology (Cambridge Institute for Medical Research) Research Technologist – Neural (STEMCELL Technologies Inc.) Scientist – Molecular Neuroscience (Loyola University Chicago) Postdoctoral Associate – hiPSC-Based Brain Organoids (Rutgers University) Postdoctoral Position – Neuroscience and Mitochondrial Physiology (University of Moncton) Postdoctoral Position – Pain in Mouse Models of Spinal Cord Injury (Indiana University) Postdoctoral Position – Spinal Cord Injury (Nanyang Technological University) PhD/Postdoctoral Research Position – Neuroscience (Max Planck Society) Postdoctoral Fellowship – Neurodegeneration (Lund University) Postdoctoral Associate – Cerebral Organoids (Weill Cornell Medicine) Multiple Faculty Positions – Neuroscience and Neuroengineering (Tsinghua University) Postdoctoral Position – Brain Injury and Repair (University of Pennsylvania) Faculty Members – Neuroscience (Mercer University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Neural Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|